Janus Henderson Group PLC Adaptive Biotechnologies Corp Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Janus Henderson Group PLC holds 46,900 shares of ADPT stock, worth $793,079. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,900
Previous 46,900
-0.0%
Holding current value
$793,079
Previous $348,000
56.9%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ADPT
# of Institutions
268Shares Held
149MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$507 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$197 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$191 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$106 Million1.68% of portfolio
-
Nikko Asset Management Americas, Inc.4.3MShares$72.7 Million0.53% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $2.42B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...